tiprankstipranks
Aziyo Biologics (ELUT)
NASDAQ:ELUT
US Market

Aziyo Biologics (ELUT) Income Statement

Compare
61 Followers

Aziyo Biologics Income Statement

Last quarter (Q3 2024), Aziyo Biologics's total revenue was $5.92M, a decrease of -3.35% from the same quarter last year. In Q3, Aziyo Biologics's net income was $1.29M. See Aziyo Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 24.75M$ 23.85M$ 47.39M$ 42.68M$ 42.90M
Gross Profit
$ 11.05M$ 11.64M$ 19.02M$ 20.56M$ 19.77M
Operating Expenses
$ 41.58M$ 41.63M$ 42.05M$ 34.16M$ 28.18M
Depreciation and Amortization
$ 3.51M$ 3.57M$ 3.73M$ 3.86M$ 3.90M
EBITDA
$ -31.92M$ -27.46M$ -15.72M$ -12.30M$ -2.63M
Operating Income
$ -30.53M$ -29.99M$ -23.03M$ -13.60M$ -8.41M
Other Income/Expenses
$ -10.70M$ -6.16M$ -1.75M$ -8.20M$ -3.50M
Pretax Income
$ -41.22M$ -36.15M$ -24.78M$ -21.80M$ -11.91M
Net Income
$ -37.66M$ -32.90M$ -24.83M$ -21.82M$ -11.94M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.07$ -2.38$ -2.38$ -2.13$ -1.12
Diluted EPS
$ -2.07$ -2.38$ -2.38$ -2.13$ -1.12
Weighted Average Shares Outstanding
18.16M 13.83M 10.44M 10.23M 10.67M
Weighted Average Shares Outstanding (Diluted)
18.16M 13.83M 10.44M 10.23M 10.67M
Currency in USD

Aziyo Biologics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis